News

The Move GBS Forward campaign highlights a promising new approach to treatment of the disease. Annexon Biosciences CEO Doug ...
BENGALURU: The Karnataka High Court appointed the wife of a retired man as his guardian to operate his three savings bank ...
While the top- and bottom-line numbers for DXC Technology (DXC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics ...
Union has “unequivocally” appealed to the Government of India (GoI) and the NSCN-K (Angmai-Mulatonu) to enter into a formal ceasefire agreement without further delay.
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...
To further our strategic development plan, preparing to initiate the open-label tanruprubart FORWARD study, measuring pharmacokinetics, pharmacodynamics, early efficacy in week 1, and safety in up to ...
Gulf Business Solutions (GBS), a leading provider of technology solutions in Saudi Arabia, has announced a strate ...
Pune: A seven-and-half-year-old boy was discharged from Deenanath Mangeshkar Hospital on May 3 after battling a ...
CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness ...